WealthSource Partners’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

WealthSource Partners’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,360	Closed	-$24K	–	480
2019 Q2	$24K	Hold	3,360	–	–	﹤0.01%	444
2019 Q1	$27K	Hold	3,360	–	–	0.01%	348
2018 Q4	$27K	Sell	3,360 -1,440	-30%	-$17.3K	0.01%	301
2018 Q3	$74K	Hold	4,800	–	–	0.02%	313
2018 Q2	$43K	Buy	+4,800	New	+$42.5K	0.01%	299

Other funds holding IDXG

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

WealthSource Partners's IDXG Position: Q3 2019 in Review

WealthSource Partners sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q3 2019, closing a stake of 3,360 shares — an estimated $24K sold.

WealthSource Partners first reported a position in IDXG in Q2 2018 and held it in 5 quarters. The position peaked at $74K in Q3 2018. 17 funds tracked by Wall St. Rank hold IDXG as of Q3 2019.

WealthSource Partners reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
WealthSource Partners sold 3,360 Interpace Biosciences, Inc. Common Stock shares in Q3 2019, an estimated $24K.
WealthSource Partners first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
WealthSource Partners's Interpace Biosciences, Inc. Common Stock position peaked at $74K in Q3 2018.
17 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q3 2019.

Based on WealthSource Partners's 13F filing for Q3 2019, filed 15 Nov 2019.